The co-founder of Regeneron has warned that blockbuster weight-loss drugs could cause “more harm than good” unless the rapid muscle loss associated with the treatments is solved, as the US biotech pushes ahead with trials of muscle-preserving medicines.
再生元(Regeneron)的聯合創辦人警告稱，除非解決與治療相關的快速肌肉流失問題，否則暢銷的減肥藥物可能會「弊大於利」，因爲美國生物技術公司正在推進保肌藥物的試驗。
您已閱讀7%（338字），剩餘93%（4297字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。